The Global Market for Cell Surface Markers Identification Equipment is Projected to Reach US$4.8 Billion by 2020

Robust Investments in Drug Discovery to Drive the Cell Surface Markers Identification Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Cell Surface Markers Identification market. The global market for Cell Surface Markers Identification Equipment is projected to reach US$4.8 billion by 2020, driven by the robustly growing investments in drug discovery and increasing demand for advanced diagnostic and laboratory equipment.

Cell surface markers, defined as proteins/antigens expressed on the surface of cells, are useful tools in identification and categorization of cells. Offering efficient capabilities in immunophenotyping, cell surface markers offer important insights on various stages and pathways of cell differentiation that have relevance in diagnosis and treatment of diseases. These proteins play an important role in understanding pathophysiological conditions such as autoimmunity, identification of stem cells, and characterization of their phenotypes for further experimental studies. Drug discovery research constitutes a major application of cell surface markers. Cell surface marker analysis facilitates researchers to evaluate the efficacy of a drug and its impact on patient’s condition. Other exciting areas include personalized medicine wherein analysis and understanding of cells isolated from patients and their response to therapy would allow the physician to make safer and effective medical decisions.

As cell level analysis relies on cell surface markers, many of drug discovery programs use cell surface marker identification instruments and reagents for evaluating the effectiveness of the drug in controlling a disease. The market has been exhibiting noticeable growth over the past few years, driven by the surge in healthcare and drug discovery research. Increased focus on lab automation is another major factor generating substantial demand for markers identification equipment. Cell surface markers detection equipment is widely used in research applications including cytological academic research and drug discovery programs. Growing prevalence of chronic disorders such as cancer and autoimmune diseases and increased need to address the medical needs of the spiraling number of patients through sophisticated and reliable technology solutions is creating a favorable environment for growth in the healthcare and life sciences sectors.

Flow cytometers are widely used for cell surface markers identification, accounting for over 2/3rd share of the total market. Flowcytometric analysis is extensively used in characterization of cells. Technological advancements and the resulting improvements in terms of accuracy, precision and speed have expanded flow cytometry applications in cellular analysis, genomic and molecular analysis, and measurement of a variety of soluble and intracellular proteins such as cell signaling pathways, cytokines, and growth factors. High-throughput flow cytometry is used for performing multiplexed cell-based and bead-based screenings.

As stated by the new market research report on Cell Surface Markers Identification, the United States constitutes the largest market worldwide. Asia-Pacific ranks as the fastest growing market, with a CAGR of over 12.4% over the analysis period, led by growing healthcare and research expenditure, move towards laboratory automation, increased access to healthcare, and proliferation of medical tourism.

Major players covered in the report include Abbott Laboratories, BD Biosciences, Beckman Coulter, Bio-Rad Laboratories, CellaVision AB, Dako Denmark A/S, eBioscience, EMD Millipore, F. Hoffmann-La Roche, Grifols, S.A, Horiba, Mindray Medical International, Ortho-Clinical Diagnostics, QIAGEN N.V., Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, among others.

The research report titled “Cell Surface Markers Identification: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in US$ Million for all major geographic markets such as the US, Canada, Japan, Europe, Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America, and Rest of World. The report also analyzes the global market for Cell Surface Markers Identification Equipment by segment – Flow Cytometers and Others (Includes Hematology Analyzers, Reagents, and Kits). 

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.